Literature DB >> 20975013

Assessing risk factors as potential screening tests: a simple assessment tool.

Nicholas J Wald1, Joan K Morris.   

Abstract

Many risk factors for disease are suggested as screening tests when there is little prospect that they could be useful in predicting disease. To avoid this, it is useful to know the relationship between the relative risk of a disease or disorder in people with high and low values of a risk factor, and the equivalent screening performance in terms of the detection rate (sensitivity) for a specified false-positive rate. We describe an interactive Risk-Screening Converter, accessible from the Internet (http://www.wolfson.qmul.ac.uk/rsc/), that transforms an odds ratio into the equivalent estimates of detection and false-positive rates. The converter is intended for general clinicians, for people engaged in research into risk factors and disease, and for those who give advice on applying such research findings into medical practice. It should help to distinguish effective screening methods from ineffective ones, and so improve clinical guidelines relating to screening and the prediction and prevention of disease.

Entities:  

Mesh:

Year:  2010        PMID: 20975013     DOI: 10.1001/archinternmed.2010.378

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  16 in total

1.  Adjusting confounders in ranking biomarkers: a model-based ROC approach.

Authors:  Tao Yu; Jialiang Li; Shuangge Ma
Journal:  Brief Bioinform       Date:  2012-03-06       Impact factor: 11.622

Review 2.  The potential of novel biomarkers to improve risk prediction of type 2 diabetes.

Authors:  Christian Herder; Bernd Kowall; Adam G Tabak; Wolfgang Rathmann
Journal:  Diabetologia       Date:  2014-01       Impact factor: 10.122

3.  [Chronic inflammation and biomarkers. Is ageing an expression of chronic inflammation?].

Authors:  D Schmidt; A Kwetkat; M Gogol
Journal:  Z Gerontol Geriatr       Date:  2011-06       Impact factor: 1.281

Review 4.  CVD screening in low-risk, asymptomatic adults: clinical trials needed.

Authors:  Tamar S Polonsky; Philip Greenland
Journal:  Nat Rev Cardiol       Date:  2012-08-14       Impact factor: 32.419

5.  The causal exposure model of vascular disease.

Authors:  Allan D Sniderman; Patrick R Lawler; Ken Williams; George Thanassoulis; Jacqueline de Graaf; Curt D Furberg
Journal:  Clin Sci (Lond)       Date:  2012-04       Impact factor: 6.124

6.  Updated Website Address.

Authors: 
Journal:  JAMA Intern Med       Date:  2021-08-01       Impact factor: 21.873

7.  Will polygenic risk scores for cancer ever be clinically useful?

Authors:  Amit Sud; Clare Turnbull; Richard Houlston
Journal:  NPJ Precis Oncol       Date:  2021-05-21

8.  Prediction of fracture risk in men: a cohort study.

Authors:  Liisa Byberg; Rolf Gedeborg; Thomas Cars; Johan Sundström; Lars Berglund; Lena Kilander; Håkan Melhus; Karl Michaëlsson
Journal:  J Bone Miner Res       Date:  2012-04       Impact factor: 6.741

9.  The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population.

Authors:  Erling Falk; Henrik Sillesen; Pieter Muntendam; Valentin Fuster
Journal:  Curr Atheroscler Rep       Date:  2011-10       Impact factor: 5.113

10.  Atherosclerosis: from biology to pharmacological treatment.

Authors:  Graziano Riccioni; Valeriana Sblendorio
Journal:  J Geriatr Cardiol       Date:  2012-09       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.